Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2019 ∙ Hermann, J. S. Featherstone, R. M. Russell, M. L. MacDonald, S. E.

Immunization Coverage of Children in Care of the Child Welfare System in High-Income Countries: A Systematic Review

  • Newborn
  • Children
  • Adolescents
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2019 ∙ Ji, Z. Jian, M. Chen, T. Luo, L. Li, L. Dai, X. Bai, R. Ding, Z. Bi, Y. Wen, S. Zhou, G. Abi, M. E. Liu, A. Bao, F.

Immunogenicity and Safety of the M72/AS01 Candidate Vaccine Against Tuberculosis: A Meta-Analysis

  • Newborn
  • Adolescents
  • Adults
  • Tuberculosis
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Mehtani, N. J. Rosman, L. Moss, W. J.

Immunogenicity and Safety of the Measles Vaccine in HIV-Infected Children: An Updated Systematic Review

  • Newborn
  • Children
  • Measles
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Dai, X. Bai, R. Jian, M. Ji, Z. Ding, Z. Wang, F. Bi, Y. Manzamaesso, A. Chen, T. Luo, L. Liu, A. Bao, F.

Immunogenicity of different dosing schedules of the human live attenuate rotavirus vaccine (RV1) in infants and children: a meta-analysis

  • Newborn
  • Children
  • Rotavirus
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Samson, S. I. Leventhal, P. S. Salamand, C. Meng, Y. Seet, B. T. Landolfi, V. Greenberg, D. Hollingsworth, R.

Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis

  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Nic Lochlainn, L. M. de Gier, B. van der Maas, N. Strebel, P. M. Goodman, T. van Binnendijk, R. S. de Melker, H. E. Hahne, S. J. M.

Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis

  • Newborn
  • Measles
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Adawi, M. Bragazzi, N. L. McGonagle, D. Watad, S. Mahroum, N. Damiani, G. Conic, R. Bridgewood, C. Mahagna, H. Giacomelli, L. Eggenhoffner, R. Mahamid, M. Pigatto, P. D. M. Amital, H. Watad, A.

Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: An evidence-informed and PRISMA compliant systematic review and meta-analysis

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Doyon-Plourde, P. Fakih, I. Tadount, F. Fortin, E. Quach, C.

Impact of influenza vaccination on healthcare utilization - A systematic review

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2019 ∙ Greyson, D. Vriesema-Magnuson, C. Bettinger, J. A.

Impact of school vaccination mandates on pediatric vaccination coverage: a systematic review

  • Children
  • Adolescents
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2019 ∙ Vadlamudi, N. K. Chen, A. Marra, F.

Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
  • Coverage
Methodological quality (AMSTAR 2):
Critically low
Loading...